Medicated Shampoo Market To Hit Value .8 Billion By 2025

Posted by Mrudula Anil Karmarkar on May 5th, 2022

The global medicated shampoo market size is expected to reach USD 14.8 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 3.0% over the forecast period. Rising concerns over hair related issues, growing consumer inclination towards hair maintenance, and new formulated product launches on a global level are projected to remain prominent market trends. Furthermore, rising awareness of maintaining beauty among working class adults in emerging economies including China, India, and Vietnam is projected to upscale the requirements of medicated shampoo over the next few years.

The Beauty and Personal Care (BPC) industry has witnessed a decline in the wake of the Covid 19 pandemic, but the impact is not as severe as seen in other industries. Although discretionary spending has reduced, the BPC market has witnessed a consumer behavioral shift towards safe and reliable products. Products that have a lower risk of contamination owing to automation and longer shelf lives helping the rationing of consumer supplies are expected to stand out in the near future. Brands are also focusing on improving their supply lines in terms of strengthening their E-commerce channel along with offering at-home wellness products, which are highly suited in this volatile business environment. Our team is diligently working towards accounting these factors in our report with the aim of providing you with the up-to-date, actionable market information and projections.

North America accounted for more than 30.0% share of the overall revenue in 2018. Strong foothold of hair care companies including Johnson & Johnson Consumer Inc. and Proctor & Gamble through extensive distribution networks in U.S. and Canada is expected to provide high market visibility of medicated shampoo. Furthermore, shifting inclination towards organic shampoo as a result of rising concerns over hazardous effects associated with the synthetically derived chemical ingredients is likely to force industry participants to incorporate natural extracts such as neem, strawberry, and other fruit flavors in the formulation of finished goods.

Dandruff and seborrheic dermatitis treatment generated a revenue of USD 3.1 billion in 2018. These products are used to remove the white flakes, reduce itchiness, and remove dead skin to give a clear and clean scalp. Rising concerns over anti-dandruff and excess oil control among the buyers have enabled the manufacturers to customize the products accordingly to meet desired specifications given by users.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/medicated-shampoo-market/request/rs1

Key industry participants include Procter & Gamble; Johnson & Johnson Consumer Inc.; Coty Inc.; Avalon Natural Products; Kao Corporation; Sanofi-Aventis Groupe; Himalaya Herbal Healthcare; and Summers Laboratories Inc. Product innovation is expected to remain a key strategy among the industry participants over the next few years.

Further key findings from the study suggest:

  • By treatment, psoriasis is expected to reach USD 2.5 billion by the end of 2025. The head lice treatment accounted for 21.5% share of the global medicated shampoo market revenue in 2018
  • The online channel generated a revenue of USD 2.8 billion in 2018
  • Asia Pacific is expected to witness the fastest CAGR of 3.5% from 2019 to 2025.

In March 2017, Proctor & Gamble launched six-variants of anti-dandruff shampoos under the brand name, “Head & Shoulders Men Ultra”. These products are manufactured by using the high performance boosters including mint and caffeine, which are available in six variants including Total Care, Instant Scalp Relief, Max Oil Control, Hair Booster, Sports Fresh, and Old Spice.

In addition, increasing disposable income among middle-income groups in the developing economies including China, India, and Brazil is enabling the consumers to raise their spending for medicated shampoo products. Over the past few years, consumers have been suffering from various hair problems due to which several brands have emerged rapidly and advance product offerings have impacted the medicated shampoo market growth positively.

Medicated shampoos containing selenium sulfide, coal tar, zinc pyrithione, and salicylic acid are often used to treat dandruff and seborrheic dermatitis. Selenium sulfide is effective in treating itchiness and white flakes caused by severe dandruff, whereas zinc pyrithione not just reduces dandruff but also adds a pleasant smell to the hair. These products are also useful in treating psoriasis, a condition in which thick and red scaly patches are visible all across the scalp. Presence of coal tar significantly reduces the rapid growth of skin cell that causes psoriasis and inflammation.

Key players in this market include Procter & Gamble; Coty Inc.; Johnson & Johnson Consumer Inc.; Avalon Natural Products; Himalaya Herbal Healthcare; Sanofi-Aventis Groupe; and Summers Laboratories Inc. In March 2017, Procter & Gamble launched a new product under the brand name, Head & Shoulders Men Ultra, which promises to deal with various hair problems such as excess oily scalp and helps in instant clean scalp, removing flakes, and rejuvenating hair texture.

Grand View Research has segmented the global medicated shampoo market on the basis of treatment, distribution channel:

Medicated Shampoo Treatment Outlook (Revenue, USD Billion, 2015 - 2025)

  • Dandruff & Sebborheic Dermatis
  • Psoriasis
  • Tinea Captis
  • Head Lice
  • Allergic Reactions

Medicated Shampoo Distribution Channel Outlook (Revenue, USD Billion, 2015 - 2025)

  • Hypermarkets/Supermarkets
  • Convenience Stores
  • Online

Like it? Share it!


Mrudula Anil Karmarkar

About the Author

Mrudula Anil Karmarkar
Joined: July 2nd, 2020
Articles Posted: 1,899

More by this author